Allozymes, a pioneering biotech company, has secured $15 million in Series A funding, positioning itself to revolutionize various industries with its cutting-edge enzymatic solutions. The funding round was spearheaded by renowned international investors Seventure Partners of France and Xora Innovation of Singapore, demonstrating strong confidence in Allozymes’ groundbreaking technology and market potential.
With this significant investment, Allozymes is set to accelerate the development and commercialization of its proprietary enzyme discovery and engineering platform. By harnessing the power of enzymes, Allozymes aims to deliver sustainable and efficient solutions across a wide range of sectors, including agriculture, food and beverage, pharmaceuticals, and more. This funding milestone marks a crucial step in Allozymes’ journey to transform industries and create a greener future through the application of its innovative enzymatic technology.
